Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The glycoprotein GPNMB is selectively elevated in the substantia nigra of Parkinson's disease patients and increases after lysosomal stress
Elizabeth B. Moloney, Alyssa Moskites, Eliza J. Ferrari, et al.
Neurobiology of Disease (2018) Vol. 120, pp. 1-11
Open Access | Times Cited: 103

Showing 1-25 of 103 citing articles:

Cell-type-specific cis-eQTLs in eight human brain cell types identify novel risk genes for psychiatric and neurological disorders
Julien Bryois, Daniela Calini, Will Macnair, et al.
Nature Neuroscience (2022) Vol. 25, Iss. 8, pp. 1104-1112
Open Access | Times Cited: 178
The Role of GPNMB in Inflammation
Marina Saade, Giovanna Araujo de Souza, Cristóforo Scavone, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 154
GBA Variants and Parkinson Disease: Mechanisms and Treatments
Laura Smith, Anthony H.V. Schapira
Cells (2022) Vol. 11, Iss. 8, pp. 1261-1261
Open Access | Times Cited: 135
Human physiomimetic model integrating microphysiological systems of the gut, liver, and brain for studies of neurodegenerative diseases
Martin Trapečar, Emile Wogram, Devon S. Svoboda, et al.
Science Advances (2021) Vol. 7, Iss. 5
Open Access | Times Cited: 123
GPNMB confers risk for Parkinson’s disease through interaction with α-synuclein
Maria E. Diaz‐Ortiz, Yunji Seo, Marijan Posavi, et al.
Science (2022) Vol. 377, Iss. 6608
Open Access | Times Cited: 101
Emerging targets of α-synuclein spreading in α-synucleinopathies: a review of mechanistic pathways and interventions
Grace m. Kuo, Ramhari Kumbhar, W. Frank Blair, et al.
Molecular Neurodegeneration (2025) Vol. 20, Iss. 1
Open Access | Times Cited: 3
Autophagy lysosomal pathway dysfunction in Parkinson's disease; evidence from human genetics
Konstantin Senkevich, Ziv Gan‐Or
Parkinsonism & Related Disorders (2019) Vol. 73, pp. 60-71
Open Access | Times Cited: 109
Proteomics in cerebrospinal fluid and spinal cord suggests UCHL1, MAP2 and GPNMB as biomarkers and underpins importance of transcriptional pathways in amyotrophic lateral sclerosis
Patrick Oeckl, Patrick Weydt, Dietmar Rudolf Thal, et al.
Acta Neuropathologica (2019) Vol. 139, Iss. 1, pp. 119-134
Closed Access | Times Cited: 97
Lipid and immune abnormalities causing age-dependent neurodegeneration and Parkinson’s disease
Penelope J. Hallett, Simone Engelender, Ole Isacson
Journal of Neuroinflammation (2019) Vol. 16, Iss. 1
Open Access | Times Cited: 90
Cell type-specific lipid storage changes in Parkinson’s disease patient brains are recapitulated by experimental glycolipid disturbance
Oeystein Roed Brekk, Jonathan Roy Honey, Seungil Lee, et al.
Proceedings of the National Academy of Sciences (2020) Vol. 117, Iss. 44, pp. 27646-27654
Open Access | Times Cited: 79
Network analysis of the progranulin-deficient mouse brain proteome reveals pathogenic mechanisms shared in human frontotemporal dementia caused by GRN mutations
Meixiang Huang, Erica Modeste, Eric B. Dammer, et al.
Acta Neuropathologica Communications (2020) Vol. 8, Iss. 1
Open Access | Times Cited: 73
Identifying drug targets for neurological and psychiatric disease via genetics and the brain transcriptome
Denis Baird, Jimmy Z. Liu, Jie Zheng, et al.
PLoS Genetics (2021) Vol. 17, Iss. 1, pp. e1009224-e1009224
Open Access | Times Cited: 70
Neurodegeneration by α-synuclein-specific T cells in AAV-A53T-α-synuclein Parkinson’s disease mice
Akua Afriyie Karikari, Rhonda L. McFleder, Eliana Ribechini, et al.
Brain Behavior and Immunity (2022) Vol. 101, pp. 194-210
Open Access | Times Cited: 62
Glucocerebrosidase-associated Parkinson disease: Pathogenic mechanisms and potential drug treatments
Matthew E. Gegg, Elisa Menozzi, Anthony H.V. Schapira
Neurobiology of Disease (2022) Vol. 166, pp. 105663-105663
Open Access | Times Cited: 48
A proteogenomic view of Parkinson’s disease causality and heterogeneity
Sérgio Kaiser, Luqing Zhang, Brit Mollenhauer, et al.
npj Parkinson s Disease (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 32
Spatial Transcriptomics-correlated Electron Microscopy maps transcriptional and ultrastructural responses to brain injury
Peter Androvic, Martina Schifferer, Katrin Perez Anderson, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 28
GPNMB is a biomarker for lysosomal dysfunction and is secreted via LRRK2-modulated lysosomal exocytosis
Erin C. Bogacki, G Longmore, Patrick A. Lewis, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access | Times Cited: 1
Glycoprotein Non-Metastatic Protein B: An Emerging Biomarker for Lysosomal Dysfunction in Macrophages
Martijn J. C. van der Lienden, Paulo Gaspar, Rolf G. Boot, et al.
International Journal of Molecular Sciences (2018) Vol. 20, Iss. 1, pp. 66-66
Open Access | Times Cited: 69
Glucocerebrosidase: Functions in and Beyond the Lysosome
Daphne E.C. Boer, Jeroen van Smeden, Joke A. Bouwstra, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 3, pp. 736-736
Open Access | Times Cited: 54
Mapping the serum proteome to neurological diseases using whole genome sequencing
Grace Png, Andrei Barysenka, L. Repetto, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 44
Blood Markers of Inflammation, Neurodegeneration, and Cardiovascular Risk in Early Parkinson's Disease
Michael Bartl, Mohammed Dakna, Sebastian Schade, et al.
Movement Disorders (2022) Vol. 38, Iss. 1, pp. 68-81
Open Access | Times Cited: 37
MALAT1 lncRNA and Parkinson’s Disease: The role in the Pathophysiology and Significance for Diagnostic and Therapeutic Approaches
M. Abrishamdar, Maryam Sadat Jalali, M. Rashno
Molecular Neurobiology (2022) Vol. 59, Iss. 9, pp. 5253-5262
Closed Access | Times Cited: 30
Prioritization of Drug Targets for Neurodegenerative Diseases by Integrating Genetic and Proteomic Data From Brain and Blood
Yi‐Jun Ge, Ya‐Nan Ou, Yue‐Ting Deng, et al.
Biological Psychiatry (2022) Vol. 93, Iss. 9, pp. 770-779
Open Access | Times Cited: 28
Expanding causal genes for Parkinson’s disease via multi-omics analysis
Xiaojing Gu, Wei‐Ming Su, Meng Dou, et al.
npj Parkinson s Disease (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 21
The regulatory role of lipophagy in central nervous system diseases
Zhuoqing Lan, Zi-yi Ge, Shu-kai Lv, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 20
Page 1 - Next Page

Scroll to top